Pomalidomide
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| The Efficacy and Safety of the Combination Therapy of Daratumumab, Cabozantinib, Pomalidomide, and Dexamethasone (D-KPd) in the Treatment of High-risk First-time Relapsed or Primary Refractory MM Patients (NCT07015021) | The First Affiliated Hospital of Soochow University | 2025-06-01 |
Track Pomalidomide automatically
Every clearance here is in the API, with alerts when new ones post.